Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-264035

Chief Financial Officer sold 33,000 shares at $240.09 ($7,922,970)

  • Chief Financial Officer acquired 33,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Pizzie Nick · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-09 Exercise or conversion : show line 1 in the form 10b5-1 +33,000 $3.50 $115,500 75,867 D
2026-06-09 Sale : show line 2 in the form 10b5-1 −33,000 $240.09 $7,922,970 42,867 D
Open-market sales · 33,000 sh · avg $240.09 · $7,922,970

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-09 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −33,000 72,000 D
Loading xslF345X06/ownership.xml…